Cancer Therapy Advisor15 小时
Pembrolizumab Improves Upon THP in HER2+ Breast Cancer
Adding pembrolizumab to THP improved pCR rates in patients with HER2-positive breast cancer in the phase 2 NeoHIP trial.
Cure Today17 小时
CAN-2409 Elicits Promising Responses in Localized Prostate Cancer
CAN-2409 resulted in disease-free survival improvements for patients with high-risk, localized prostate cancer.